Age-Related Changes in Cell Yield and Viability of Feline Adipose Tissue-Derived Mesenchymal Stem Cells (fAD-MSCs)

Introduction

The field of regenerative medicine has revolutionized biomedical research, with stem cell biology playing a critical role in tissue engineering and therapeutic applications. Among various stem cell sources, adipose tissue-derived mesenchymal stem cells (AD-MSCs) are highly valued for their accessibility, high yield, and regenerative potential. This blog explores a recent study on age-related changes in cell yield and viability of feline Adipose Tissue-Derived Mesenchymal Stem Cells (fAD-MSCs).

Study Overview

A study conducted by Shazia Nissar et al. investigated the effects of age on cell yield and viability of fAD-MSCs. The researchers collected omental adipose tissue samples from felines of different age groups and processed them using enzymatic digestion to isolate mesenchymal stem cells.

Key Findings

  • The highest cell yield was observed in younger cats (7-9 months old), indicating a strong potential for regenerative medicine applications.
  • Viability rates were significantly higher in younger groups, gradually decreasing with age.
  • The study confirmed that stem cell proliferation rate declines as the animal ages, making younger-derived stem cells a better candidate for therapeutic applications.

Implications for Regenerative Medicine

According to The American Society of Gene & Cell Therapy (ASGCT), younger mesenchymal stem cells have greater differentiation capacity and regenerative abilities, making them more effective for therapeutic interventions.

DOI and Further Reading

Disclaimer:
This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reuse of this material will not be handled by the author of this article. You may provide us with feedback in the comments section.